Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 12,700 shares at $17.75 ($225K) on 2023-06-16, disclosed to the SEC on 2023-06-20.
Open-market purchase of $225k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |